Free Trial

Viridian Therapeutics (VRDN) Insider Trading & Ownership

Viridian Therapeutics logo
$20.82 -0.72 (-3.34%)
(As of 12/17/2024 ET)

Viridian Therapeutics (NASDAQ:VRDN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.65%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$40.62 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get VRDN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Viridian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VRDN Insider Buying and Selling by Quarter

Viridian Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/27/2024Stephen F MahoneyCEOBuy21,400$23.33$499,262.00  
9/27/2024Thomas W BeethamCOOBuy5,000$23.41$117,050.00  
9/13/2024Fairmount Funds Management LlcDirectorBuy1,600,000$18.75$30,000,000.00  
1/22/2024Fairmount Funds Management LlcDirectorBuy476,190$21.00$9,999,990.00  
(Data available from 1/1/2013 forward)

VRDN Insider Trading Activity - Frequently Asked Questions

The list of insiders at Viridian Therapeutics includes Barrett Katz, Fairmount Funds Management Llc, Jonathan Violin, Lara Meisner, Scott Dunseth Myers, Stephen F Mahoney, and Thomas W Beetham. Learn more on insiders at VRDN.

0.65% of Viridian Therapeutics stock is owned by insiders. Learn more on VRDN's insider holdings.

The following insiders have purchased VRDN shares in the last 24 months: Fairmount Funds Management Llc ($39,999,990.00), Scott Dunseth Myers ($261,805.00), Stephen F Mahoney ($499,262.00), and Thomas W Beetham ($117,050.00).

Insiders have purchased a total of 2,112,090 VRDN shares in the last 24 months for a total of $40,878,107.00 bought.

The following insiders have sold VRDN shares in the last 24 months: Barrett Katz ($2,750,668.70), Jonathan Violin ($1,840,000.00), and Lara Meisner ($1,253,581.45).

Insiders have sold a total of 168,434 Viridian Therapeutics shares in the last 24 months for a total of $5,844,250.15 sold.

Viridian Therapeutics Key Executives

  • Mr. Stephen F. Mahoney J.D. (Age 53)
    MBA, CEO, President & Director
    1 recent trades
  • Dr. Eric N. Olson Ph.D.
    Co-Founder & Chairman of Scientific Advisory Board
  • Dr. Michael R. Bristow M.D. (Age 79)
    Ph.D., Co-Founder & Member of the Scientific Advisory Board
  • Dr. Marvin H. Caruthers Ph.D. (Age 84)
    Co-Founder & Scientific Advisory Board Member
  • Mr. Vahe Bedian Ph.D.
    Co-Founder & Scientific Advisor
  • Mr. Seth Harmon
    Senior VP of Finance and Accounting, Principal Financial & Accounting Officer
  • Mr. Thomas W. Beetham J.D. (Age 54)
    MBA, Chief Operating Officer
    1 recent trades
  • Ms. Jennifer Tousignant J.D.
    Chief Legal Officer
  • Mr. John A. Jordan
    Vice President of Investor Relations & Corporate Communications
  • Mr. Anthony Casciano (Age 47)
    Chief Commercial Officer


This page (NASDAQ:VRDN) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners